CELL INTELLIGENCE · 肿瘤细胞治疗研究

γδ T 细胞调节小细胞肺癌中的抗肿瘤免疫

γδ T cells modulate anti-tumor immunity in small cell lung cancer.

T 细胞重定向疗法在肺癌中的应用——临床试验的综合分析

T-cell redirecting therapies in lung cancer - a comprehensive analysis of clinical trials.

多种治疗策略如何重塑小细胞肺癌肿瘤免疫微环境：从放疗到工程化免疫治疗

How diverse therapeutic strategies reshape the tumor immune microenvironment in small cell lung cancer: from radiation to engineered immunotherapies.

靶向 DLL3 的 VHH 基 CAR-T 细胞在小细胞肺癌模型中显示高疗效

VHH-Based CAR-T Cells Targeting DLL3 Show High Efficacy in Small Cell Lung Cancer Models.

蛋白质组学分析鉴定 CLDN3 为小细胞肺癌的肿瘤选择性治疗靶点

Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer.

双 DLL3/CD56 靶向 CAR-T 细胞中的平行 4-1BB 信号触发适应性增殖与功能性持久性以根除小细胞肺癌

Parallel 4-1BB Signaling in Dual DLL3/CD56-Targeting CAR-T Cells Triggers Adaptive Proliferation and Functional Persistence to Eradicate Small Cell Lu

JAK1 抑制剂 golidocitinib 增强 DLL3 靶向 CAR-T 治疗小细胞肺癌的疗效

The JAK1 inhibitor golidocitinib boosts therapeutic potency of DLL3-targeted CAR-T therapy for small cell lung cancer.

DLL3 CAR-T 细胞联合 dnTGFBR2 治疗一例复发性小细胞肺癌患者的安全性和有效性：病例报告

Safety and efficacy of DLL3 CAR-T cells armored with dnTGFBR2 in a subject with recurrent small-cell lung cancer: case report.

广泛期小细胞肺癌中靶向细胞表面抗原与表观遗传学的现有及新兴疗法：临床医生入门

Current and emerging therapies targeting cell surface antigens and epigenetics in extensive stage small cell lung cancer: primer for clinicians.

训练免疫预激活的 DLL3 靶向 CAR 巨噬细胞用于根除小细胞肺癌

Trained immunity-primed DLL3-targeted CAR macrophages for the eradication of small cell lung cancer.

抗 DLL3 CAR-Ms 在实体瘤治疗中展现出显著潜力，未来可能为 SCLC 提供可行的临床策略。